Webinar - The Clinical Impact of Early Detection of Extended-Spectrum Beta Lactamase (ESBL) Bacteremia in Hospitalized Patients Online, Online

With the recent improvements of molecular blood culture identification (BCID) panels, time to pathogen and resistance profile identification generated from a positive blood culture has been drastically reduced. Compared to conventional culture and antibiotic susceptibility testing, this rapid turnaround allows the microbiology lab to deliver results to the clinical teams more efficiently to allow for prompt administration of the correct regimen of antibiotics and antifungals. In this webinar, Dr. Aya Haghamad, a Pharmacy Advisor at Northwell Health, will highlight the hospital networks experience implementing the ePlex BCID-GN Panel and the outcomes they experienced from a clinical perspective. She will detail the significant improvements in time to appropriate therapy that were observed after the addition of a rapid molecular test for ESBL was instituted in this large hospital network. Register to learn about the clinical impact of early detection of ESBL bacteremia in hospitalized patients.